<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01070173</url>
  </required_header>
  <id_info>
    <org_study_id>5H08</org_study_id>
    <nct_id>NCT01070173</nct_id>
  </id_info>
  <brief_title>Ghrelin Levels in Children With Poor Growth</brief_title>
  <official_title>Ghrelin Levels in Children With Gastrointestinal Symptoms and/or Poor Growth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tripler Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tripler Army Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that low serum ghrelin levels may characterize a group of
      patients with poor weight gain and/or linear growth who do not have any other identified
      cause for growth failure. These patients may present with a variety of complaints and are
      often evaluated by both pediatric endocrinologists and pediatric gastroenterologists. The
      investigators hypothesize that ghrelin has a physiologically important role in linear growth
      and that chronic diseases of the gastrointestinal system, such as H. Pylori infection or
      celiac disease, may alter serum ghrelin levels in children. Low ghrelin levels may be a
      factor leading to poor growth, potentially by altering growth hormone secretion and/or by
      decreasing appetite. By measuring ghrelin levels in children with short stature and in
      children with gastrointestinal disease, the investigators will further elucidate the possible
      physiologic role of ghrelin in childhood growth and how it may be altered in conditions
      causing short stature and in certain gastrointestinal diseases.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total Ghrelin Level</measure>
    <time_frame>Will be measured with baseline screening labs at enrollment.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Acylated Ghrelin Level</measure>
    <time_frame>Will be measured with baseline screening labs at enrollment.</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Idiopathic Short Stature</condition>
  <condition>Failure to Thrive</condition>
  <arm_group>
    <arm_group_label>Short Stature</arm_group_label>
    <description>Poor linear growth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Poor Weight Gain (Failure-To-Thrive)</arm_group_label>
    <description>Poor Weight Gain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isolated Gastrointestinal Symptoms</arm_group_label>
    <description>No growth symptoms</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Twenty-five (25) patients seen for evaluation of short stature in the pediatric
        endocrinology clinic will have serum ghrelin levels measured in addition to their usual
        routine bloods tests.

        Twenty-five (25) patients will be selected from patients who present with chronic
        gastrointestinal symptoms (symptoms of gastrointestinal disease for greater than 6 weeks or
        recurrent symptoms) and who have poor growth.

        The remaining 25 will be selected from patients with chronic gastrointestinal symptoms
        (symptoms of gastrointestinal disease for greater than 6 weeks or recurrent symptoms) who
        have normal growth.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To be included in the short stature group, subjects must have had short stature,
             defined height less than -2 SD for gender and age or an abnormal growth velocity for
             gender and age).

          -  To be included in the failure-to-thrive group, subjects must have had poor weight
             gain, defined as weight less than -2 SD for gender and age or an abnormal weight
             velocity for gender and age.

          -  Patients in both groups will be evaluated for the presence of chronic gastrointestinal
             symptoms, defined as symptoms of gastrointestinal disease for greater than 6 weeks or
             recurrent symptoms. Patients who were affected in both weight and height will be
             stratified by which measurement was more severely affected, with poor weight gain
             being the primary problem in the &quot;failure-to-thrive&quot; grouping (Group 2) and &quot;poor
             linear growth&quot; being the primary problem in the short stature group (Group 1).

          -  Patients who have had chronic gastrointestinal symptoms, defined as symptoms of
             gastrointestinal disease for greater than 6 weeks or recurrent symptoms, but normal
             stature and growth, will be analyzed separately (Group 3).

        Exclusion Criteria:

          -  Must not have a known diagnosis as an etiology for growth failure or GI symptoms prior
             to presentation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jordan Pinsker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tripler Army Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tripler Army Medical Center/Dept of Pediatrics</name>
      <address>
        <city>Tripler AMC</city>
        <state>Hawaii</state>
        <zip>96859</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Pinsker JE, Ondrasik D, Chan D, Fredericks GJ, Tabisola-Nuesca E, Fernandez-Aponte M, Focht DR, Poth M. Total and acylated ghrelin levels in children with poor growth. Pediatr Res. 2011 Jun;69(6):517-21. doi: 10.1203/PDR.0b013e3182181b2c.</citation>
    <PMID>21386753</PMID>
  </results_reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2010</study_first_submitted>
  <study_first_submitted_qc>February 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2010</study_first_posted>
  <results_first_submitted>December 8, 2012</results_first_submitted>
  <results_first_submitted_qc>January 15, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 18, 2013</results_first_posted>
  <last_update_submitted>January 15, 2013</last_update_submitted>
  <last_update_submitted_qc>January 15, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tripler Army Medical Center</investigator_affiliation>
    <investigator_full_name>Jordan Pinsker</investigator_full_name>
    <investigator_title>Chief, Pediatric Endocrinology</investigator_title>
  </responsible_party>
  <keyword>Ghrelin</keyword>
  <keyword>short stature</keyword>
  <keyword>failure to thrive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dwarfism</mesh_term>
    <mesh_term>Failure to Thrive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Fifty-two patients were recruited into the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Short Stature</title>
          <description>Poor linear growth Group</description>
        </group>
        <group group_id="P2">
          <title>Poor Weight Gain (Failure-To-Thrive)</title>
          <description>Poor Weight Gain (Failure-To-Thrive) Group</description>
        </group>
        <group group_id="P3">
          <title>Isolated Gastrointestinal Symptoms</title>
          <description>Isolated Gastrointestinal Symptoms Group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Short Stature</title>
          <description>Poor linear growth</description>
        </group>
        <group group_id="B2">
          <title>Poor Weight Gain (Failure-To-Thrive)</title>
          <description>Poor Weight Gain (Failure-To-Thrive)</description>
        </group>
        <group group_id="B3">
          <title>Isolated Gastrointestinal Symptoms</title>
          <description>Isolated Gastrointestinal Symptoms</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="11"/>
            <count group_id="B4" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Particpants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Ghrelin Level</title>
        <time_frame>Will be measured with baseline screening labs at enrollment.</time_frame>
        <population>All participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Short Stature</title>
            <description>Poor linear growth Group</description>
          </group>
          <group group_id="O2">
            <title>Poor Weight Gain (Failure-To-Thrive)</title>
            <description>Poor Weight Gain (Failure-To-Thrive) Group</description>
          </group>
          <group group_id="O3">
            <title>Isolated Gastrointestinal Symptoms</title>
            <description>Isolated Gastrointestinal Symptoms Group</description>
          </group>
        </group_list>
        <measure>
          <title>Total Ghrelin Level</title>
          <population>All participants.</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1063" spread="77"/>
                    <measurement group_id="O2" value="1264" spread="245"/>
                    <measurement group_id="O3" value="1157" spread="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Acylated Ghrelin Level</title>
        <time_frame>Will be measured with baseline screening labs at enrollment.</time_frame>
        <population>All participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Short Stature</title>
            <description>Poor linear growth Group</description>
          </group>
          <group group_id="O2">
            <title>Poor Weight Gain (Failure-To-Thrive)</title>
            <description>Poor Weight Gain (Failure-To-Thrive) Group</description>
          </group>
          <group group_id="O3">
            <title>Isolated Gastrointestinal Symptoms</title>
            <description>Isolated Gastrointestinal Symptoms Group</description>
          </group>
        </group_list>
        <measure>
          <title>Acylated Ghrelin Level</title>
          <population>All participants.</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="190" spread="34"/>
                    <measurement group_id="O2" value="465" spread="128"/>
                    <measurement group_id="O3" value="176" spread="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Short Stature</title>
          <description>Poor linear growth Group</description>
        </group>
        <group group_id="E2">
          <title>Poor Weight Gain (Failure-To-Thrive)</title>
          <description>Poor Weight Gain (Failure-To-Thrive) Group</description>
        </group>
        <group group_id="E3">
          <title>Isolated Gastrointestinal Symptoms</title>
          <description>Isolated Gastrointestinal Symptoms Group</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="11"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jordan Pinsker</name_or_title>
      <organization>Tripler Army Medical Center</organization>
      <phone>808-433-6338</phone>
      <email>jordan.pinsker@us.army.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

